Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition

F Chen, J Lin, R Kang, D Tang, J Liu - Molecular Carcinogenesis - Wiley Online Library
Paclitaxel serves as the cornerstone chemotherapy for ovarian cancer, yet its prolonged
administration frequently culminates in drug resistance, presenting a substantial challenge …
被引用次数：1 相关文章

Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition

F Chen, J Lin, R Kang, D Tang… - Molecular …, 2024 - utsouthwestern.elsevierpure.com
Paclitaxel serves as the cornerstone chemotherapy for ovarian cancer, yet its prolonged
administration frequently culminates in drug resistance, presenting a substantial challenge …

Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition

F Chen, J Lin, R Kang, D Tang, J Liu - Molecular carcinogenesis - pubmed.ncbi.nlm.nih.gov
Paclitaxel serves as the cornerstone chemotherapy for ovarian cancer, yet its prolonged
administration frequently culminates in drug resistance, presenting a substantial challenge …

Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition.

F Chen, J Lin, R Kang, D Tang, J Liu - Molecular Carcinogenesis, 2024 - europepmc.org
Paclitaxel serves as the cornerstone chemotherapy for ovarian cancer, yet its prolonged
administration frequently culminates in drug resistance, presenting a substantial challenge …